Resultados da busca - Hans‐Jochem Kolb
- Mostrando 1 - 20 resultados de 33
- Ir para a próxima página
-
1
Graft-versus-leukemia effects of transplantation and donor lymphocytes por Hans‐Jochem Kolb
Publicado em 2008Revisão -
2
-
3
Infection and GVHD por Hans‐Jochem Kolb, Daniela Weber, Belinda Pinto Simões, Ernst Holler
Publicado em 2018Artigo -
4
Graft-versus-leukemia reactions in allogeneic chimeras por Hans‐Jochem Kolb, Christoph Schmid, A. John Barrett, Dolores J. Schendel
Publicado em 2003Revisão -
5
Evidence of Peripheral Blood‐Derived, Plastic‐Adherent CD34 <sup>−/low</sup> Hematopoietic Stem Cell Clones with Mesenchymal Stem Cell Characteristics por Ralf Huss, Claudia Lange, Eva M. Weissinger, Hans‐Jochem Kolb, Karin Thalmeier
Publicado em 2000Artigo -
6
Plasminogen Activator Inhibitor-1 Confirms the Diagnosis of Hepatic Veno-Occlusive Disease in Patients With Hyperbilirubinemia After Bone Marrow Transplantation por Christoph Salat, Ernst Holler, Hans‐Jochem Kolb, Brigitte Reinhardt, Rudolf Pihusch, W. Wilmanns, Erhard Hiller
Publicado em 1997Artigo -
7
CD6-depleted mobilized stem cells for modification of HVG and GVH reactions after HLA-haploidentical marrow transplantation por Hans‐Jochem Kolb, I. Bigalke, Belinda Pinto Simões, Christine S. Falk, Johanna Tischer, Wolfgang Hill, Georg Ledderose
Publicado em 2005Artigo -
8
-
9
-
10
-
11
Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies por Juçara Gastaldi Cominal, Maira da Costa Cacemiro, Belinda Pinto-Simões, Hans‐Jochem Kolb, Kelen Cristina Ribeiro Malmegrim, Fabíola Attié de Castro
Publicado em 2019Revisão -
12
Effect of Prior Blood Transfusions on Marrow Grafts: Abrogation of Sensitization by Procarbazine and Antithymocyte Serum por Rainer Storb, G. L. Floersheim, Paul L. Weiden, Theodore Graham, Hans‐Jochem Kolb, K. G. Lerner, Maria‐Louise Schroeder, E. Donnall Thomas
Publicado em 1974Artigo -
13
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT por Donald Milligan, M C Ruiz de Elvira, Hans‐Jochem Kolb, Anthony H. Goldstone, Giovanna Meloni, A. Z. S. Rohatiner, Philippe Colombat, Norbert Schmitz
Publicado em 1999Artigo -
14
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation por Eva M. Weissinger, Eric Schiffer, Bernd Hertenstein, James L.M. Ferrara, Ernst Holler, Michael Stadler, Hans‐Jochem Kolb, Axel R. Zander, Petra Zürbig, Markus Kellmann, Arnold Ganser
Publicado em 2007Artigo -
15
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells por Andreas Moosmann, Iris Bigalke, Johanna Tischer, Leah Schirrmann, Julitta Kasten, Stefanie Tippmer, Marina Leeping, Dušan Prevalšek, Gundula Jaeger, Georg Ledderose, Josef Mautner, Wolfgang Hammerschmidt, Dolores J. Schendel, Hans‐Jochem Kolb
Publicado em 2010Artigo -
16
Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Fac... por Christoph Schmid, Myriam Labopin, Arnon Nagler, Martin Bornhäuser, Jürgen Finke, Athanasios Fassas, Liisa Volin, Günhan Gürman, Johan Maertens, Pierre Bordigoni, Ernst Holler, Gerhard Ehninger, Emmanuelle Polge, Norbert Claude Gorin, Hans-Jochem Kolb, Vanderson Rocha
Publicado em 2007Artigo -
17
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose por Cesare Guglielmi, William Arcese, Francesco Dazzi, Ronald Brand, Donald Bunjes, Leo F. Verdonck, A Schattenberg, Hans-Jochem Kolb, Per Ljungman, Agnès Devergie, Andrea Bacigalupo, Marta Gómez, Mauricette Michallet, Ahmet Elmaağaclı, Aloïs Gratwohl, Jane Apperley, Dietger Niederwieser
Publicado em 2002Artigo -
18
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation por Nicole Engel, Alicia Rovó, Manuela Badoglio, Myriam Labopin, Grzegorz Basak, Yves Béguin, D Guyotat, Per Ljungman, Arnon Nagler, A Schattenberg, Thomas Schroeder, Wilfried Schroyens, Johanna Tischer, Gèrard Socié, Hans‐Jochem Kolb, André Tichelli, Nina Salooja, Rafael F. Duarte
Publicado em 2018Artigo -
19
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease por Mary E.D. Flowers, Jane F. Apperley, Koen van Besien, Ahmet Elmaağaclı, Andrew Grigg, Vijay Reddy, Andrea Bacigalupo, Hans-Jochem Kolb, Luís Fernando S. Bouzas, Mauricette Michallet, H. Miles Prince, Robert Knobler, Dennis Parenti, José Luis Rodríguez Gallo, Hildegard Greinix
Publicado em 2008Artigo -
20
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation por Christoph Schmid, Michael Schleuning, Rainer Schwerdtfeger, Bernd Hertenstein, Eva M. Weissinger, Donald Bunjes, Stephanie von Harsdorf, Christoph Scheid, Udo Holtick, Hildegard Greinix, Felix Keil, Barbara Schneider, Michael Sandherr, Gesine Bug, Johanna Tischer, Georg Ledderose, Michael Hallek, Wolfgang Hiddemann, Hans-Jochem Kolb
Publicado em 2006Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Transplantation
Immunology
Biology
Hematopoietic stem cell transplantation
Surgery
Gastroenterology
Leukemia
Genetics
Myeloid leukemia
Oncology
Stem cell
Bone marrow
Chemotherapy
Graft-versus-host disease
Haematopoiesis
Randomized controlled trial
Cancer research
Disease
Biochemistry
Cyclophosphamide
Gene
Hematology
Imatinib
Acute leukemia
Chronic myelogenous leukemia
Cumulative incidence
Environmental health
Imatinib mesylate